Recent developments in drug discovery for leishmaniasis and human African trypanosomiasis
Chem Rev
.
2014 Nov 26;114(22):11305-47.
doi: 10.1021/cr500365f.
Epub 2014 Nov 3.
Authors
Advait S Nagle
1
,
Shilpi Khare
1
,
Arun Babu Kumar
,
Frantisek Supek
1
,
Andriy Buchynskyy
,
Casey J N Mathison
1
,
Naveen Kumar Chennamaneni
,
Nagendar Pendem
,
Frederick S Buckner
,
Michael H Gelb
,
Valentina Molteni
1
Affiliation
1
Genomics Institute of the Novartis Research Foundation , 10675 John Jay Hopkins Drive, San Diego, California 92121, United States.
PMID:
25365529
PMCID:
PMC4633805
DOI:
10.1021/cr500365f
No abstract available
Publication types
Review
MeSH terms
Antiprotozoal Agents / chemical synthesis*
Antiprotozoal Agents / chemistry
Antiprotozoal Agents / therapeutic use*
Drug Design*
Humans
Leishmaniasis / drug therapy*
Trypanosomiasis / drug therapy*
Substances
Antiprotozoal Agents
Grants and funding
WT_/Wellcome Trust/United Kingdom
R01 AI054384/AI/NIAID NIH HHS/United States
R01 AI070218/AI/NIAID NIH HHS/United States
R01 AI106850/AI/NIAID NIH HHS/United States